Last reviewed · How we verify
Chromium Cr 51 Edetate — Competitive Intelligence Brief
unknown
chromium (51Cr) edetate
Other
Live · refreshed every 30 min
Target snapshot
Chromium Cr 51 Edetate (chromium (51Cr) edetate). Chromium (51Cr) edetate is a radiopharmaceutical that works by emitting radiation to diagnose or treat certain medical conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chromium Cr 51 Edetate TARGET | chromium (51Cr) edetate | unknown | chromium (51Cr) edetate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (chromium (51Cr) edetate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chromium Cr 51 Edetate CI watch — RSS
- Chromium Cr 51 Edetate CI watch — Atom
- Chromium Cr 51 Edetate CI watch — JSON
- Chromium Cr 51 Edetate alone — RSS
- Whole chromium (51Cr) edetate class — RSS
Cite this brief
Drug Landscape (2026). Chromium Cr 51 Edetate — Competitive Intelligence Brief. https://druglandscape.com/ci/chromium-51cr-edetate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing